Please use this identifier to cite or link to this item:
Title: Global Issues of Radiopharmaceutical Access and Availability: a Nuclear Medicine Global Initiative Project.
Austin Authors: Cutler, Cathy S;Bailey, Elizabeth A;Kumar, Vijay;Schwarz, Sally W;Bom, Henry Hee-Seung;Hatazawa, Jun;Paez, Diana;Orellana, Pilar;Louw, Lizette;Mut, Fernando;Kato, Hiroki;Chiti, Arturo;Frangos, Savvas;Fahey, Frederic H;Dillehay, Gary;Oh, Seoung Jun;Lee, Dong Soo;Lee, Sze Ting ;Nunez-Miller, Rodolfo;Bandopadhyaya, Guru Pad;Pradhan, Prasanta;Scott, Andrew M 
Affiliation: Brookhaven National Laboratory, Upton, MA, USA
, United States
Department of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA
University of Melbourne, Melbourne, Australia
, Australia
Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, NSW, Australia
Department of Nuclear Medicine & PET, Westmead Hospital & The Children's Hospital at Westmead, and University of Sydney, NSW, Australia
chool of Cancer Medicine, La Trobe University, Melbourne, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia
Washington University School of Medicine, St Louis, MO, USA
Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Jeollanam, Korea
Department of Quantum Cancer Therapy, Research Center for Nuclear Physics, Osaka University, Osaka, Japan
Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria
University of the Witwatersrand, South Africa
Nuclear Medicine Service, Italian Hospital, Montevideo, Uruguay
Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan
Humanitas University, and Nuclear Medicine Unit, Humanitas Research Hospital - IRCCS
Bank of Cyprus Oncology Center, Cyprus..
Department of Radiology, Division of Nuclear Medicine, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
Excel Diagnostics and Nuclear Oncology Center, Houston, TX, USA
Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India., India
Department of Nuclear Medicine, Sanjay Gandhi Post Graduate Institute of Nuclear Medicine (SGPGIMS), Lucknow, India
Issue Date: 9-Jul-2020 2020-07-09
Publication information: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020; online first: 9 July
Abstract: The Nuclear Medicine Global Initiative (NMGI) was formed in 2012 by 13 international organizations to promote human health by advancing the field of nuclear medicine and molecular imaging by supporting the practice and application of nuclear medicine. The first project focused on standardization of administered activities in pediatric nuclear medicine and resulted in two manuscripts. For its second project the NMGI chose to explore issues impacting on access and availability of radiopharmaceuticals around the world. Methods: Information was obtained by survey responses from 35 countries on available radioisotopes, radiopharmaceuticals and kits for diagnostic and therapeutic use. Issues impacting on access and availability of radiopharmaceuticals in individual countries were also identified. Results: Detailed information on radiopharmaceuticals utilized in each country, and sources of supply, was evaluated. Responses highlighted problems in access particularly due to the reliance on a sole provider, regulatory issues and reimbursement, as well as issues of facilities and workforce particularly in low- and middle-income countries. Conclusion: Strategies to address access and availability of radiopharmaceuticals are outlined, to enable timely and equitable patient access to nuclear medicine procedures worldwide. In the face of disruptions to global supply chains by the COVID-19 outbreak, renewed focus on ensuring reliable supply of radiopharmaceuticals is a major priority for nuclear medicine practice globally.
DOI: 10.2967/jnumed.120.247197
ORCID: 0000-0002-6656-295X
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
PubMed URL: 32646881
Type: Journal Article
Subjects: Molecular Imaging
Quality Assurance
global issues
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jun 5, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.